Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment
Advances in Protein Chemistry and Structural Biology · 2024
DOI: 10.1016/bs.apcsb.2024.02.003 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Advances in Protein Chemistry and Structural Biology, 2024. Verfasst von Sangita Dey und 3 weiteren Autor:innen. Beteiligte Einrichtung: CSO Department, Cellworks Research India Pvt Ltd, Bengaluru, Karnataka, India. Hauptthemen laut MEDLINE: Neoplasms, Synthetic Biology, Receptors, Chimeric Antigen. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 187 Literaturangaben.
Abstract (Originalsprache)
This book chapter highlights a comprehensive exploration of the transformative innovations in the field of cancer immunotherapy. CAR (Chimeric Antigen Receptor) T-cell therapy represents a groundbreaking approach to treat cancer by reprogramming a patient immune cells to recognize and destroy cancer cells. This chapter underscores the critical role of synthetic biology in enhancing the safety and effectiveness of CAR T-cell therapies. It begins by emphasizing the growing importance of personalized medicine in cancer treatment, emphasizing the shift from one-size-fits-all approaches to patient-specific solutions. Synthetic biology, a multidisciplinary field, has been instrumental in customizing CAR T-cell therapies, allowing for fine-tuned precision and minimizing unwanted side effects. The chapter highlights recent advances in gene editing, synthetic gene circuits, and molecular engineering, showcasing how these technologies are optimizing CAR T-cell function. In summary, this book chapter sheds light on the remarkable progress made in the development of CAR T-cell therapies using synthetic biology, providing hope for cancer patients and hinting at a future where highly personalized and effective cancer treatments are the norm.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- CSO Department, Cellworks Research India Pvt Ltd, Bengaluru, Karnataka, India.
- Department of Animal Biology, School of Life Sciences, University of Hyderabad, Hyderabad, India.
- ICAR, National Institute of Veterinary Epidemiology and Disease Informatics, Bengaluru, Karnataka, India.
- Department of Medical Biochemistry and Biophysics, Karolinska Institute, Solna, Sweden. Electronic address: rajan.kumar.pandey@ki.se.
Zitieren
APA
Dey, S., Devender, M., Rani, S., & Pandey, R. K. (2024). Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment. Advances in Protein Chemistry and Structural Biology. https://doi.org/10.1016/bs.apcsb.2024.02.003
Vancouver
Dey S, Devender M, Rani S, Pandey RK. Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment. Advances in Protein Chemistry and Structural Biology. 2024. doi:10.1016/bs.apcsb.2024.02.003
BibTeX
@article{Dey2024,
author = {Dey, Sangita and Devender, Moodu and Rani, Swati and Pandey, Rajan Kumar},
title = {Recent advances in CAR T-cell engineering using synthetic biology: Paving the way for next-generation cancer treatment},
journal = {Advances in Protein Chemistry and Structural Biology},
year = {2024},
doi = {10.1016/bs.apcsb.2024.02.003}
}
EUVIMED